Author:
Linye He,Zijing Xia,Wei Peng,Chao He,Chuan Li,Tianfu Wen
Funder
State Key Scientific and Technological Research Programs
Postdoctoral Sustentation Fund of West China Hospital, Sichuan University, China
Science and Technological Supports Project of Sichuan Province
Health and Family Planning Commission of Sichuan Province
Science and Technology Project of Chengdu
Publisher
Ovid Technologies (Wolters Kluwer Health)
Reference42 articles.
1. Update on HCC management and review of the new EASL guidelines;Aghemo;Gastroenterol Hepatol (N Y),2018
2. Chinese Clinical Practice Guidelines for transarterial chemoembolization of hepatocellular carcinoma;Zhonghua Gan Zang Bing Za Zhi,2019
3. Comparison of hepatic resection and transarterial chemoembolization for solitary hepatocellular carcinoma;Zhang;World J Gastroenterol,2015
4. Can IVIM help predict HCC recurrence after hepatectomy?;Zhang;Eur Radiol,2019
5. Time to recurrence, but not recurrence-free survival, should be the endpoint used to predict early recurrence after HCC resection;Yan;J Hepatol,2019
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献